Victoria Richon

All filings by Victoria Richon on record concern Epizyme, Inc., in the capacity of board member. Between 11 June 2021 and 12 August 2022, the trades on record add up to 3 filings.

Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Most recently, on 16 August 2022, the filings show a transaction in Epizyme, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.